FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+20.9%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$38.4B
AUM Growth
+$3.99B
(+12%)
Cap. Flow
-$616M
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
28.98%
Holding
520
New
61
Increased
186
Reduced
165
Closed
55
Top Buys
| 1 |
CME Group
CME
|
$217M |
| 2 |
Qualcomm
QCOM
|
$199M |
| 3 |
Appian
APPN
|
$180M |
| 4 |
DraftKings
DKNG
|
$173M |
| 5 |
Advanced Micro Devices
AMD
|
$170M |
Top Sells
| 1 |
Alibaba
BABA
|
$445M |
| 2 |
Boston Scientific
BSX
|
$340M |
| 3 |
Fidelity National Information Services
FIS
|
$297M |
| 4 |
Intercontinental Exchange
ICE
|
$229M |
| 5 |
Crown Castle
CCI
|
$210M |
Sector Composition
| 1 | Technology | 35.81% |
| 2 | Healthcare | 20.96% |
| 3 | Consumer Discretionary | 14.53% |
| 4 | Communication Services | 9.02% |
| 5 | Financials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Merck
MRK
$212B
| $2.23M | 0.01% |
28,549
| – | – |
|
327
argenx
ARGX
$45.9B
| $2.14M | 0.01% |
7,271
-4,145
| -36% | -$1.22M |
|
328
CVS Health
CVS
$93.6B
| $2.04M | 0.01% |
29,907
| – | – |
|
329
NextEra Energy, Inc.
NEE
$146B
| $2.01M | 0.01% |
26,075
-117
| -0.4% | -$9.03K |
|
330
Chevron
CVX
$310B
| $1.99M | 0.01% |
23,512
-127
| -0.5% | -$10.7K |
|
331
Ralph Lauren
RL
$18.9B
| $1.98M | 0.01% |
+19,071
| New | +$1.98M |
|
332
Walmart
WMT
$801B
| $1.95M | 0.01% |
40,515
| – | – |
|
333
Schrodinger
SDGR
$1.41B
| $1.84M | ﹤0.01% |
23,290
-525
| -2% | -$41.6K |
|
334
Sarepta Therapeutics
SRPT
$1.96B
| $1.81M | ﹤0.01% |
10,636
-405,488
| -97% | -$69.1M |
|
335
Winnebago Industries
WGO
$1.03B
| $1.74M | ﹤0.01% |
29,095
+16,619
| +133% | +$996K |
|
336
Eaton
ETN
$136B
| $1.7M | ﹤0.01% |
14,179
| – | – |
|
337
Altria Group
MO
$112B
| $1.7M | ﹤0.01% |
41,374
| – | – |
|
338
McDonald's
MCD
$224B
| $1.67M | ﹤0.01% |
7,783
+938
| +14% | +$201K |
|
|
CTLT
339
DELISTED
CATALENT, INC.
CTLT
| $1.63M | ﹤0.01% |
15,642
-19,485
| -55% | -$2.03M |
|
340
Pfizer
PFE
$141B
| $1.54M | ﹤0.01% |
41,817
-21,852
| -34% | -$804K |
|
341
Tanger
SKT
$3.94B
| $1.52M | ﹤0.01% |
+152,061
| New | +$1.52M |
|
342
Zoom
ZM
$25B
| $1.5M | ﹤0.01% |
4,435
-36,232
| -89% | -$12.2M |
|
343
Ocular Therapeutix
OCUL
$2.37B
| $1.48M | ﹤0.01% |
71,513
-59,326
| -45% | -$1.23M |
|
|
SGEN
344
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.48M | ﹤0.01% |
8,436
-5,790
| -41% | -$1.01M |
|
345
Castle Biosciences
CSTL
$683M
| $1.47M | ﹤0.01% |
21,839
+11,460
| +110% | +$769K |
|
|
CCXI
346
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.44M | ﹤0.01% |
23,235
-524
| -2% | -$32.5K |
|
347
Royalty Pharma
RPRX
$15.6B
| $1.44M | ﹤0.01% |
28,716
+17,608
| +159% | +$881K |
|
348
Denali Therapeutics
DNLI
$2.26B
| $1.41M | ﹤0.01% |
+16,878
| New | +$1.41M |
|
349
Amgen
AMGN
$153B
| $1.41M | ﹤0.01% |
6,110
-62
| -1% | -$14.3K |
|
350
AT&T
T
$212B
| $1.38M | ﹤0.01% |
63,388
| – | – |
|